2023-05-16 16:58:22 ET
- Editas Medicine ( NASDAQ: EDIT ) appoints Erick Lucera as Executive VP and CFO, effective May 17.
- Lucera replaces Michelle Robertson, who served as CFO since January 2020 and is stepping down.
- Robertson will remain in an advisory role until August 16, 2023, ensuring a smooth transition.
- Lucera brings over 30 years of financial, operational, and investment experience in life sciences.
- Previously CFO of AVEO Pharmaceuticals and Valeritas, Lucera played key roles in company growth and acquisitions .
For further details see:
Editas Medicine appoints Erick Lucera as CFO, Michelle Robertson steps down